Gene therapy leads to improved quality of life in patients with sickle cell disease and beta thalassemia
Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia, according to two ...
Aug 27, 2025
0
22

